For most medications beyond semaglutide injections, you cant see pricing without a provider review first
Acta Crystallogr Sect F Struct Biol Cryst Commun
Retatrutide is a next-generation synthetic peptide acting as a triple receptor agonist, simultaneously targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
2016;7(Suppl 1):806
Vial Duration At 10 units/injection, 5x/week (loading phase): 50 units per week 200 units per vial (2mL = 200 units on U-100 syringe) One vial lasts 4 weeks At 5 units/injection, 3x/week (maintenance half the loading dose): 15 units per week One vial lasts ~13 weeks Affiliate disclosure: vendor links in this article are affiliate links The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you
Mairiang E, Laha T, Kaewkes S, Loukas A, Bethony J, Brindley PJ, Sripa B